 |
|
Plasma and Urinary Catecholamines and Their Metabolites in Chronic Renal Failure
Riad Darwish, MD;
Alan N. Elias, MD;
Nosratola D. Vaziri, MD;
Madeleine Pahl, MD;
David Powers, MD;
John D. Stokes, MD
Arch Intern Med. 1984;144(1):69-71.
Abstract
• The effect of chronic renal failure (CRF) on the plasma concentration and urinary excretion of catecholamines and their metabolites was studied in 14 patients with varying degrees of chronic renal failure who had creatinine clearances of 19 to 77 mL/min. The results were compared with those obtained in a group of age-matched normal controls. Plasma catecholamine concentrations were significantly higher in the CRF patients compared with age-matched normal controls (456.9±303.1 v 278.5±81.1 pg/mL). The urinary metanephrine (0.6±0.6 mg/g creatinine) and vanillylmandelic acid (VMA) (6.6±4.2 mg/g creatinine) were within the normal range. No significant correlations were found between creatinine clearance and urinary metanephrine and VMA excretion or with the plasma catecholamine concentrations. Our observations indicate that, despite the decrease in creatinine clearance, urinary VMA and metanephrine determinations are valid screening tests for pheochromocytoma in patients with compromised renal function. Plasma catecholamine concentrations, however, show moderate elevation with decreasing renal function.
(Arch Intern Med 1984;144:69-71)
Author Affiliations
From the Divisions of Endocrinology and Metabolism (Drs Elias and Stokes) and Nephrology (Drs Darwish, Vaziri, Pahl, and Powers), the Department of Medicine, University of California, Irvine.
Footnotes
Accepted for publication July 20, 1983.
Reprint requests to Division of Endocrinology and Metabolism, University of California—Irvine, Medical Center, 101 City Drive South, Orange, CA 92668 (Dr Elias).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Evaluation of a New Method for the Analysis of Free Catecholamines in Plasma Using Automated Sample Trace Enrichment with Dialysis and HPLC
Dutton et al.
Clin. Chem. 1999;45:394-399.
ABSTRACT
| FULL TEXT
Renal Parenchymal Hypertension: Current Concepts of Pathogenesis and Management
Preston et al.
Arch Intern Med 1996;156:602-611.
ABSTRACT
Plasma Norepinephrine, Epinephrine, and Dopamine Levels in End-Stage Renal Disease: Effect of Hemodialysis
Elias et al.
Arch Intern Med 1985;145:1013-1015.
ABSTRACT
Snuff-Induced Hypertension in Pheochromocytoma
McPhaul et al.
JAMA 1984;252:2860-2862.
ABSTRACT
|
